Boehringer Ingelheim Pharmaceuticals, Inc. - Comment
Posted : 10/27/2010     ID ：FDA-2010-D-0246-0003     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET

LTS Lohmann Therapie-Systeme AG - Comment
Posted : 10/27/2010     ID ：FDA-2010-D-0246-0004     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET

GlaxoSmithKline - Comment
Posted : 10/27/2010     ID ：FDA-2010-D-0246-0005     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET

Mylan Technologies Inc. - Comment
Posted : 11/02/2010     ID ：FDA-2010-D-0246-0006     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET

Biotechnology Industry Organization (BIO - Comment
Posted : 11/02/2010     ID ：FDA-2010-D-0246-0007     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET

Pfizer Inc. - Comment
Posted : 11/02/2010     ID ：FDA-2010-D-0246-0008     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET

sanofi-aventis - Comment
Posted : 11/02/2010     ID ：FDA-2010-D-0246-0009     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET

Amgen, Inc .- Comment
Posted : 11/02/2010     ID ：FDA-2010-D-0246-0010     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET

LTS Lohmann Therapie-Systeme AG - Comment
Posted : 12/21/2010     ID ：FDA-2010-D-0246-0011     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET

Mylan Technologies, Inc. - Comment
Posted : 12/21/2010     ID ：FDA-2010-D-0246-0012     Agency : FDA

Comment Period Closed
Nov 01,2010 11:59 PM ET